CollPlant Biotechnologies (CLGN) EBIT Margin (2017 - 2025)
Historic EBIT Margin for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to 4554.55%.
- CollPlant Biotechnologies' EBIT Margin rose 1089954500.0% to 4554.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 107.27%, marking a year-over-year increase of 273400.0%. This contributed to the annual value of 3349.71% for FY2024, which is 32811600.0% down from last year.
- According to the latest figures from Q3 2025, CollPlant Biotechnologies' EBIT Margin is 4554.55%, which was up 1089954500.0% from 1775.42% recorded in Q2 2025.
- CollPlant Biotechnologies' EBIT Margin's 5-year high stood at 4417.35% during Q1 2024, with a 5-year trough of 113550.0% in Q3 2024.
- Its 5-year average for EBIT Margin is 7534.73%, with a median of 835.18% in 2021.
- Per our database at Business Quant, CollPlant Biotechnologies' EBIT Margin tumbled by 2000000000bps in 2021 and then soared by 1089954500bps in 2025.
- Over the past 5 years, CollPlant Biotechnologies' EBIT Margin (Quarter) stood at 1227.1% in 2021, then plummeted by -557bps to 8062.07% in 2022, then soared by 79bps to 1694.98% in 2023, then crashed by -43bps to 2423.17% in 2024, then tumbled by -88bps to 4554.55% in 2025.
- Its last three reported values are 4554.55% in Q3 2025, 1775.42% for Q2 2025, and 80.19% during Q1 2025.